BioLife Solutions Inc (BLFS)

1.84
0.03 1.66
NASDAQ : Health Care
Prev Close 1.81
Open 1.80
Day Low/High 1.80 / 1.84
52 Wk Low/High 1.46 / 4.18
Volume 18.98K
Avg Volume 444.40K
Exchange NASDAQ
Shares Outstanding 12.88M
Market Cap 23.32M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioLife Solutions' CryoStor® Integrated In Kolon Group's Cell-Mediated Gene Therapy For Osteoarthritis

BioLife Solutions' CryoStor® Integrated In Kolon Group's Cell-Mediated Gene Therapy For Osteoarthritis

Approval to Market Invossa™ Filed with Korean Ministry of Food and Drug Safety

BioLife Solutions (BLFS) Is Strong On High Volume Today

BioLife Solutions (BLFS) Is Strong On High Volume Today

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a strong on high relative volume candidate

BioLife Solutions (BLFS) Weak On High Volume

BioLife Solutions (BLFS) Weak On High Volume

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a weak on high relative volume candidate

New Journal Articles Cite Expanded Use Of BioLife Solutions Products In Clinical Cell Therapy Applications

New Journal Articles Cite Expanded Use Of BioLife Solutions Products In Clinical Cell Therapy Applications

CryoStor® Clinical Grade Cell Freeze Media Enabling Development of Novel Regenerative Medicine Therapies for Large Disease States

BioLife Solutions Announces 2015 Biopreservation Media Revenue Growth Of 30%

BioLife Solutions Announces 2015 Biopreservation Media Revenue Growth Of 30%

Expanded Biopreservation Media Product Adoption, SaaS Cold Chain App Deployment, Planned Entry into Organ Preservation Solutions Market Set Stage for 2016 Growth

BioLife Solutions Distributor STEMCELL Technologies Will Test The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

BioLife Solutions Distributor STEMCELL Technologies Will Test The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

evo Smart Shippers Could be Used to Transport a Variety of Temperature Sensitive Products for Research in Areas such as Cellular Therapies, Blood Cancers, and Solid Tumors

BioLife Solutions Customer Capricor Therapeutics Provides Update On Heart Failure Cell Therapy Safety Data At American Heart Association Scientific Sessions

BioLife Solutions Customer Capricor Therapeutics Provides Update On Heart Failure Cell Therapy Safety Data At American Heart Association Scientific Sessions

Clinical Grade CryoStor® Cryopreservation Media Used to Freeze and Administer Cells to Patients in DYNAMIC Clinical Trial

Kiadis Pharma Utilizes BioLife Solutions HypoThermosol® To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101™ T Cell Therapy For Blood Cancers

Kiadis Pharma Utilizes BioLife Solutions HypoThermosol® To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101™ T Cell Therapy For Blood Cancers

ATIR101™ Offers Potential Curative Stem Cell Transplant Option for the 35% of Eligible Cancer Patients Who Do Not Find a Matching Donor in Time

BioLife Solutions Reports Record Revenue And Provides Operations Update For Q3 2015

BioLife Solutions Reports Record Revenue And Provides Operations Update For Q3 2015

33% Biopreservation Media Revenue Growth over Q3 2014

BioLife Solutions Announces HemaCare Will Validate The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

BioLife Solutions Announces HemaCare Will Validate The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

evo Smart Shippers Will Transport Leukopak Starting Material for CAR-T Cellular Immunotherapies Currently in 3rd Party Clinical Trials for Blood Cancers and Solid Tumors

BioLife Solutions CryoStor® Commercial Grade Freeze Media Embedded In TC Biopharm ImmuniCell® Clinical Trial For Various Cancers

BioLife Solutions CryoStor® Commercial Grade Freeze Media Embedded In TC Biopharm ImmuniCell® Clinical Trial For Various Cancers

Novel T Cell Based Immunotherapy to be Evaluated in Melanoma, Kidney, and Lung Cancer in Groundbreaking Clinical Trial Design

Strong On High Volume: BioLife Solutions (BLFS)

Strong On High Volume: BioLife Solutions (BLFS)

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a strong on high relative volume candidate

BioLife Sciences (BLFS) Stock Spikes as Clinical Trial Meets Primary Endpoint

BioLife Sciences (BLFS) Stock Spikes as Clinical Trial Meets Primary Endpoint

BioLife Sciences (BLFS) shares are up over 60% to after customer TiGenix's clinical trial meets primary endpoint.

BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint

BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint

HypoThermosol® Cell Storage/Shipping Media to be Used in Commercial Manufacturing of Allogeneic Expanded Stem Cells for Complex Perianal Fistula in Crohn's Disease Patients